Verena Schöning

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Lymph Node Metastasis

Top Venues

The Journal of antimicrobial chemotherapy

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Juergen Drewe, Verena Schöning, Ombeline Danton, Alexander Schenk, Georg Boonen
Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in Cimicifuga racemosa as Critical Mediators of AMPK Activation. Pharmaceutics 16 (4) (2024)
Juergen Drewe, Verena Schöning, Ombeline Danton, Alexander Schenk, Georg Boonen
Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in Cimicifuga racemosa as Critical Mediators of AMPK Activation. Pharmaceutics 16 (4) (2024)
Laura Hermann, Verena Schöning, Sarah Dräger, Katharina M Rentsch, Stephan Moser, Nicolas Gürtler, Parham Sendi, Michael Osthoff, Felix Hammann
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Laura Hermann, Verena Schöning, Sarah Dräger, Katharina M Rentsch, Stephan Moser, Nicolas Gürtler, Parham Sendi, Michael Osthoff, Felix Hammann
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection. The Journal of antimicrobial chemotherapy (2024)
Verena Schöning, Felix Hammann
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients. Pharmaceutics 14 (9) (2022)
Juergen Drewe, Ernst Küsters, Felix Hammann, Matthias Kreuter, Philipp Boss, Verena Schöning
Modeling Structure-Activity Relationship of AMPK Activation. Molecules (Basel, Switzerland) 26 (21) (2021)